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Silk-elastin-like proteins (SELPs) are a family of genetically engineered recombinant protein 
polymers exhibiting mechanical and biological properties suited for a wide range of applications in 
the biomedicine and materials fields. They are being explored as the next generation of biomaterials 
but low productivities and use of antibiotics during production undermine their economic viability 
and safety. We have developed an industrially relevant, scalable, fed-batch process for the high level 
production of a novel SELP in E. coli in which the commonly used antibiotic selection marker of the 
expression vector is exchanged for a post segregational suicide system, the separate-component-
stabilisation system (SCS). SCS significantly augments SELP productivity but also enhances the product 
safety profile and reduces process costs by eliminating the use of antibiotics. Plasmid content increased 
following induction but no significant differences in plasmid levels were discerned when using SCS or 
the antibiotic selection markers under the controlled fed-batch conditions employed. It is suggested 
that the absence of competing plasmid-free cells improves host cell viability and enables increased 
productivity with SCS. With the process developed, 12.8 g L−1 purified SELP was obtained, this is the 
highest SELP productivity reported to date and clearly demonstrates the commercial viability of these 
promising polymers.
Materials and biomaterials based on proteins have attracted much attention in recent years due to their unique 
mechanical and biological properties1–4 which rival those of synthetic polymers and lend them to numerous 
applications in a wide range of areas5–11. These protein based polymers (PBPs) are expected to substitute synthetic 
polymers in many applications as they offer the advantages of being monodisperse, biodegradable, biocompat-
ible and more environmentally friendly1–3. Furthermore, the genetically encoded template-based synthesis of 
these polymers provides for precise control of their design and the fabrication of novel customised biopolymers 
tailored for a particular application. Some potential applications include drug delivery, tissue engineering and as 
constituents of implanted medical devices, as well as surgical applications such as soft tissue augmentation and 
bone repair5–11.
Most commonly, PBPs are inspired by naturally occurring fibrous proteins such as silk, elastin and collagen 
and make use of the repetitive amino acid sequence motifs characteristic of these proteins and responsible for 
their favourable mechanical properties1,2. We have synthesised a number of novel artificial block copolymers 
combining the repetitive amino acid sequence motifs of silk and elastin12. These silk-elastin-like proteins (SELPs) 
combine the crystallinity and mechanical strength of silk with the high resilience and water solubility of elastin in 
a single structure. They have been successfully processed into hydrogels, fibers and films and shown to be suitable 
for application as biomaterials in tissue engineering, namely as wound dressing for skin regeneration13 and in 
ophthalmic applications14, but also in general materials science as transparent insulating material for photonics 
and electronics14. In addition, SELPs are also promising candidates for use in drug and gene delivery, tissue cul-
ture and as biodegradable plastics1,2,15.
The widespread application of SELPs and PBPs is currently limited by their low production levels16–20 and 
hence high production costs, with the highest SELP productivity reported prior to initiation of our studies being 
only 85 mg per litre of production culture20. In an attempt to enhance the commercial viability of these novel 
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polymers we undertook a project aimed at increasing SELP productivity and developing a scalable cost effec-
tive production process for these21,22. Our initial study focused on optimising batch production in the E. coli 
BL21(DE3)-pET expression system via an in-depth empirical approach comparing all process variables and ena-
bled an increase in productivity up to 500 mg/L purified SELP21. In addition, factors potentially limiting further 
improved productivities were identified and included an accumulation of the metabolic byproduct acetate to 
toxic levels, plasmid instability of culturable cells and increased host cell metabolic burden following induction 
of production21. Subsequently, we circumvented the former limitation by developing and optimising a scalable 
fed-batch process which reduced acetate accumulation and increased SELP yield to 4.3 g L−1, the highest reported 
value for any PBP to date22. In the present study, we attempted to address the latter limitations identified and 
further increase SELP productivity.
Our previous studies have shown that ampicillin resistance as a selective marker for plasmid stabilisation 
during high cell density production of proteins is ineffective due to the rapid degradation of ampicillin by the 
antibiotic resistance protein β -lactamase21. This ineffectiveness of ampicillin, in addition to the deprecation 
by regulatory authorities of its use in biotherapeutics and biomaterials production due to safety concerns23–25, 
prompted us to investigate other plasmid stabilisation systems. Indeed, use of β -lactam antibiotics such as ampi-
cillin poses safety risks associated with their potential for causing serious hypersensitivity reactions in patients 
and for leading to the spread of antibiotic resistance traits to the environments25,26. Furthermore, their use, 
and the necessity for additional purification and testing to ensure their absence in the final product leads to 
higher process costs. The antibiotic kanamycin is more readily accepted25 but a recently developed antibiotic 
free system, the separate-component-stabilisation system (SCS)26,27, offers a means of avoiding the use of costly 
antibiotics and potentially improving both plasmid segregational stability and product yield and safety. This 
post-segregational stabilisation system employs a toxin producing host which kills host cells that have lost the 
plasmid and an anti-toxin producing expression vector which inactivates the toxin, thereby ensuring persis-
tence of plasmid-containing cells only. In addition, as compared to antibiotic resistance markers, SCS has an 
improved safety profile as it is a naturally occurring system innocuous to eukaryotic cells26. Furthermore, it is 
expected to impose a reduced metabolic burden on host cells due to the small sizes of the toxin (100 amino 
acids) and anti-toxin (90 amino acids) as well as the regulated expression of these (toxin production only in the 
absence of anti-toxin)25–27. In contrast, the relatively large antibiotic-resistance proteins (β -lactamase: 263 amino 
acids + 23 amino acid signal sequence; aminoglycoside 3′ -phosphotransferase: 271 amino acids) are constitu-
tively expressed from the pET expression vectors and indeed have already been shown to have a deleterious effect 
on host cells24,28,29.
In this study, ampicillin and kanamycin resistance markers, as well as the SCS system and a plasmid construct 
devoid of any antibiotic resistance marker were compared for the fed-batch production of a SELP and the pro-
duction process optimised for improved product yield. In addition, a detailed comparative characterisation of the 
processes and of the effects on SELP productivity and host cell metabolism, physiology and integrity was carried 
out and allowed for a better understanding of the impact and operation of the plasmid stabilisation systems 
examined.
Results
Plasmid instability negatively impacts product yield and process economics and is a major concern in the indus-
trial production of proteins. In our earlier studies optimising the production of a novel SELP (SELP-59-A), a 
rapid reduction in the proportion of culturable cells containing plasmid was observed following induction of 
production21,22. In the present study we attempted to investigate this further by comparing the use of three dif-
ferent plasmid stabilisation systems in the fed-batch production of SELP-59-A: ampicillin resistance (AmpR), 
kanamycin resistance (KanR) and the Separate Component Stabilisation System (SCS + AmpR). In addition, we 
investigated the effect of removing the antibiotic resistance gene from the SCS expression vector (SCS) to examine 
if the resultant reduced plasmid size and reduced metabolic burden would affect process performance.
SCS as a Tool for Improving SELP Productivity. A modified, previously developed fed-batch process 
with a shortened pre-induction phase (induction at a dry cell weight of 25 g L−1) and prolonged post-induction 
phase (8 h) was employed for the high cell density production of SELP-59-A with each of the 4 constructs pre-
pared. 5 ± 0.6 g L−1 purified SELP was obtained with both SCS constructs (SCS + AmpR and SCS) under the con-
ditions used, whereas 3.5 ± 0.5 g L−1 was obtained with the AmpR construct and 3.4 ± 0.5 g L−1 with the KanR 
construct. This represents a ~40% increase for the SCS system and clearly demonstrates the effectiveness of this 
in increasing recombinant protein yield.
Comparing Process Performance. For all four constructs examined, similar biomass production and 
glucose accumulation profiles were observed and, with the exception of lactic acid, highly similar metabolic 
byproduct accumulation profiles were also noted (Fig. 1). Dry cell weight (DCW) increased during fed-batch 
feeding and initially also following induction (for ~3 h) but then eventually decreased, probably resultant of the 
increased metabolic stress imposed on host cells. This is believed to be due to a deviation of cell resources from 
biomass production to recombinant protein production and is commonly reported with E. coli as an expression 
host21,22,30,31. Glucose, malic acid, succinic acid, formic acid, acetic acid and ethanol were maintained at low con-
centrations (< 1 g L−1) during the process but, as previously reported22, lactic acid drastically increased following 
induction (Fig. 1b). Lactic acid concentrations up to approximately 1 to 1.5 g L−1 for cultures with the AmpR and 
KanR constructs were observed but use of the SCS constructs resulted in higher concentrations, averaging around 
3 g L−1. As previously discussed22, this increase in lactic acid production following induction is probably resultant 
of a diversion of cell resources during SELP production. Therefore, the higher lactic acid levels observed with 
the SCS constructs are probably related to the higher SELP productivity with these constructs and hence greater 
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pathway deregulation. Finally, the similar results observed with both SCS constructs, in the presence and absence 
of the ampicillin selection marker gene, indicate that the resistance marker has little effect on the host under the 
conditions used here.
Plasmid Stability Versus Host Cell Culturability. For monitoring of plasmid segregational sta-
bility, initially, the most commonly used method was employed in which the number of culturable cells on 
antibiotic-containing media is calculated as a percentage of that on antibiotic-free media (Fig. 2a). Hence only the 
productions with the AmpR, KanR and SCS + AmpR vectors could be investigated.
Figure 1. Monitoring of process parameters during the fed-batch phase of production. Results for the dry 
cell weight (DCW) and glucose concentrations as a function of time (a,c,e and g) and the variation in organic 
acids and ethanol levels as monitored by HPLC (b,d,f and h) are shown for the AmpR (a and b), KanR (c and d), 
SCS + AmpR (e and f) and SCS (g and h) constructs. The vertical dotted line indicates the time point of IPTG 
induction. Induction was carried out at a dry cell weight of 25 g L−1 with 3 mM IPTG for 8 hours. Error bars 
display the standard deviation of three repeat productions.
www.nature.com/scientificreports/
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From Fig. 2a it can be seen that, as previously reported21,22, use of the ampicillin selection vector resulted in 
a rapid reduction in the proportion of plasmid-containing culturable cells following induction. 100% of cultur-
able cells contained plasmid before induction and already at 6 hours post induction only plasmid free cells were 
detected under the conditions used. Similar results were observed with the KanR marker (Fig. 2a). However, 
with the SCS system all culturable cells were found to contain plasmid under the conditions used, even after 
8 hours of induction. This suggests higher plasmid content for the fermentations with the SCS system. However, 
and in contrast to this, the comparative quantification of the intracellular plasmid content in the bioreactor by 
both agarose gel visualisation (Fig. 2b) and quantitative PCR (qPCR, Fig. 2c) indicated no significant differences 
between the various constructs. For the latter (Fig. 2c), it can be seen that plasmid content increased during the 
first ~3 to 4 hours and then levelled off at the higher levels attained with all constructs and with no significant 
difference being observed. Similarly, for the agarose gel study, bands are poorly detectable under the conditions 
used before induction, but plasmid content increases following induction to higher comparable levels with all 
constructs, thereby further demonstrating that no significant differences in plasmid content were detected with 
the techniques used in this study.
Figure 3 shows the results for the culturable cell counts with the AmpR, SCS + AmpR and SCS constructs as 
well as the calculated number of plasmid-bearing and plasmid-free cells with the AmpR marker. No plasmid-free 
cells were observed for the SCS constructs but this is not unexpected with the protocol used, as these, even if 
present in the bioreactor culture medium would be prevented from growing on the LB plate medium due to toxin 
production from the host chromosome. Furthermore, while an initial increase in cell density was observed fol-
lowing induction in all cases (Fig. 1), in contrast, here (Fig. 3) it can be seen that a very rapid decline in culturable 
cell numbers immediately occurs with the AmpR construct. The number of culturable plasmid-containing cells 
drastically decreased throughout the experiment but the total (plasmid-free + plasmid-containing) culturable cell 
number eventually levelled off due to the growth of plasmid-free cells. With the SCS system, an initial increase 
during the first hour following induction was indeed observed for the total cell count, which is 100% plasmid con-
taining, but this was then also followed by a rapid decrease in cell numbers. These discrepancies, taken together 
with Fig. 2b and c where similar plasmid content is noted, suggests that the culturable cell counts (Fig. 3) and 
related culturable cell plasmid stability measurements (Fig. 2a) used here are not a true measure of plasmid stabil-
ity. They do not simply indicate, as originally suggested, increased plasmid content with the SCS construct, but are 
more a measure of cell culturability or colony forming ability, indicating a more rapid loss of cell viability and cul-
turability when using the AmpR construct. Indeed, in agreement with this, our flow cytometry assessment of cell 
viability using propidium iodide (PI) as probe (Fig. 4) indicated a more rapid loss of membrane integrity for cells 
with the AmpR construct. Here, live cells with intact membranes exclude the PI dye whereas it easily penetrates 
dead or damaged cells and interacts with cell DNA leading to diffuse red fluorescence when excited with blue light 
at 488 nm. It can be seen from Fig. 4 that the onset of the PI-DNA interaction and fluorescence occurs earlier for 
cultures with the AmpR construct than for both SCS constructs and hence indicates a more rapid accumulation 
of compromised cells for the former.
Cell morphology was also studied but no significant differences were observed with the various constructs 
(Fig. 5). At the time of induction, the majority of cells show typical E. coli size and shape, but with increasing 
induction time an increasing number of cells with ‘pinched’ and transparent terminals as well as cell fragmenta-
tion and an increase in the proportion of elongated cells is seen under the conditions used. Such changes in cell 
structure are indicative of cell stress and have been previously reported during recombinant protein production 
in E. coli32.
Figure 2. Plasmid stability following induction. The comparative analysis of plasmid stability/content by 
culturable cell counts (a) agarose gel analysis (b) and RT-qPCR (c) are shown for the fed-batch productions 
with the AmpR, KanR, SCS + AmpR and SCS constructs. The culturable cell count displays the number of cells 
forming colonies on antibiotic-containing media as a percentage of the total number of culturable cells. Note 
that SCS and SCS + AmpR gave the same results and hence overlap in (a). The agarose gel analysis provides a 
visual comparison of the intracellular plasmid content before and following 8 hours induction. qPCR results are 
expressed as the fold ratio of the normalized plasmid amount. Error bars display the standard deviation of three 
repeat productions.
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Maximising SELP-59-A Productivity. Having shown that both SCS constructs studied allowed for sim-
ilarly improved SELP productivity, construct SCS was chosen for further studies to determine the maximum 
achievable SELP productivity due to the absence of the antibiotic resistance marker on its backbone. This con-
struct was used with the previously optimised fed-batch process wherein the DCW on induction was increased to 
75 g L−1 (the limit achievable with the bioreactor system used) but here, as a result of the improved post induction 
viability of cells with this construct, longer post induction times were investigated.
From Fig. 6 it can be seen that following induction DCW initially increased before levelling off and then 
decreasing. Glucose concentrations were maintained at low levels throughout the duration of the experiment 
but organic acids increased, with in particular lactic acid, but also malic and formic acid increasing signifi-
cantly. Furthermore, the concentration of acetic acid, and to a lesser extent ethanol, suddenly increased 10 hours 
post-induction, which concomitant with a reduction of DCW is indicative of cell disruption. A strong increase 
in culture viscosity, probably due to a release of chromosomal DNA, and the release of proteins to the extracel-
lular environment as observed by SDS analysis supports this. Reduced SELP yields were hence observed with 
the 12 h post-induction period (9.3 ± 2 g L−1) and the highest production was observed 8 hours post-induction 
(12.8 ± 2 g L−1), with lower amounts being obtained for the shorter 4 hour post induction time (6.8 ± 1 g L−1).
Discussion
In this study, it is shown that use of the SCS system for the fed-batch production of SELP-59-A in E. coli signifi-
cantly enhances productivity as compared to the use of antibiotic selection markers. With the optimised process 
developed herein 12.8 g L−1 purified SELP was obtained and represents the highest reported SELP productivity 
to date, being 3-fold higher than that obtained with our previously optimised fed-batch process22 and 150-fold 
higher than that reported by other groups20. Indeed, this SCS system offers many advantages for the fed-batch 
production of recombinant proteins in E. coli. It not only improves product yield, but also improves the safety pro-
file by eliminating the use of antibiotics and antibiotic resistance markers and reduces costs by negating the need 
Figure 3. Culturable cell numbers following induction. The total number of colony forming units 
(enumerated on LB media) for the fed-batch production with the AmpR (black), SCS + AmpR (red) and SCS 
(blue) constructs are shown. The numbers of plasmid-bearing cells (enumerated on LB + Amp media) and 
those calculated for plasmid-free cells are shown for the AmpR construct only. All culturable cells for the 
SCS + AmpR and SCS constructs contained plasmid, no plasmid-free cells were detected, hence the total cell 
numbers shown here also represent the number of plasmid-containing cells for these. Error bars display the 
standard deviations for three repeat productions.
Figure 4. Flow cytometry analysis of host cell membrane permeability. The % of propidium iodide stained 
cells for the AmpR (black), SCS + AmpR (red) and SCS (blue) constructs are shown as a function of the post-
induction time. Error bars display the standard deviations for three repeat productions.
www.nature.com/scientificreports/
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for antibiotic addition and supplementary purification and testing to ensure product safety. It is suitable for the 
GMP production of proteins and biotherapeutics such as PBPs and its use here in the scalable fed-batch process 
demonstrates its potential in industrially relevant processes. Furthermore, its use in the present study for the high 
level production of a novel SELP demonstrates the commercial viability of SELPs and PBPs in general and should 
allow for a more widespread acceptance of these.
No significant differences in process performance or host cell physiology were noted when the SCS system 
was used in the presence or absence of an antibiotic selection marker. Interestingly, previous studies have indi-
cated that constitutive expression of antibiotic resistance markers negatively affects host cells and in fact marker 
accumulation up to levels as high as 20% of total cellular protein29 and even inclusion body formation have been 
reported23. This imposes a metabolic load on host cells and it has been shown that its elimination can improve 
process performance, namely for plasmid production processes23. However, protein overproduction imposes a 
severe metabolic burden on host cells30,31, as was seen here for SELP overproduction, and it is possible that the 
negative effects resultant from the β -lactamase are negligible as compared to the effects imposed by this overpro-
duction33 and hence are masked by these.
Our studies investigating plasmid stability using the traditional approach of enumerating the number 
of plasmid-containing colony-forming cells as a proportion of the total number of culturable cells indi-
cated an apparent increased stability with the SCS system (Fig. 2a). Even after 8 hours induction, 100% of 
the colony-forming units were plasmid-bearing whereas no plasmid-bearing culturable cells were detected 
6 hours post induction with the AmpR system under the conditions used. This suggests a higher number of 
plasmid-containing cells and higher plasmid content for the fermentations with the SCS system which could 
allow for the higher SELP productivities observed, yet, in contrast, our quantitative studies did not reveal 
Figure 5. Scanning electron micrographs of E. coli host cells at 0, 1, 2, 4, 6 and 8 hours post-induction . 
Only the results for the fed-batch productions with SCS + AmpR are shown, no significant differences were seen 
with any of the other constructs studied. Images were acquired at a magnification of 3000× .
Figure 6. Process parameters for the fed-batch production process with the SCS vector construct. Results 
for the dry cell weight (DCW) and glucose concentrations as a function of time (a) and the variations in organic 
acid and ethanol concentrations as monitored by HPLC (b) are shown for the 12 hour post-induction period. 
The vertical dotted line indicates the time point of IPTG induction. Induction was carried out at a dry cell 
weight of 75 g L−1 with 1 mM IPTG. Error bars display the standard deviation of three repeat productions.
www.nature.com/scientificreports/
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evidence of increased plasmid content. The comparative quantification of the intracellular plasmid content 
by both agarose gel visualisation (Fig. 2b) and qPCR (Fig. 2c) did not indicate significant differences between 
the various constructs examined under the conditions used. With all constructs, plasmid content initially 
increased and then levelled off at similar higher levels. Such an initial increase in plasmid content has in fact 
been previously reported34 and is believed to be due to the decreased cell division following induction being 
accompanied by continued plasmid replication and hence a resultant higher copy number per cell. Also, while 
the equivalent plasmid content observed for all constructs (Fig. 2b and c) appears somewhat contradictory to 
the culturable cell plasmid stability results (Fig. 2a), equal plasmid content under the conditions used may not 
be unexpected as the SCS system is a post-segregational killer system27,33,35,36. It is not a partitioning system 
that obliges daughter cells to take up a copy of the plasmid during cell division, but rather it prevents the out-
growth and proliferation of plasmid-free cells by toxin inactivation of the host cell DNA gyrase27,33,35,36. Thus, 
in the true sense of the term ‘plasmid stability’, which is a measure of the likelihood with which a plasmid is 
inherited by daughter cells at cell division, the SCS system would not be expected to enable an enhancement. 
In the present study, identical fed-batch processes were used with all constructs and hence, as was indeed 
observed here, the rate of formation of plasmid-free cells and thus also the plasmid content, could be expected 
to be similar in all cases. Indeed, such results are consistent with a previous study where it was argued that 
postsegregational killing systems do not increase plasmid stability36. Thus, it can be concluded that, under the 
controlled fed-batch production conditions of our study, with a reduced post-induction feeding rate, equal 
concentrations of plasmid were observed with all constructs and thereby indicates that something, other than 
plasmid stabilisation, allowed for the increased SELP production obtained.
In relation to the culturable-cells plasmid stability study, it must be noted that the SCS system prevents 
outgrowth of plasmid-free cells but with the AmpR construct these can grow and indeed outcompete the slower 
growing plasmid-containing cells and hence reduce the proportion of these and lead to the results observed 
(Fig. 2a). That is to say, the relative, but not the absolute level of plasmid-containing cells is reduced with 
AmpR. In addition, as discussed earlier, plasmid-free cells for the SCS system, even if present in the bioreactor, 
would not be able to form visible colonies and would not be detected with the plating techniques used here for 
measuring plasmid stability. Therefore, the culturable cell plasmid stability test most commonly used is inap-
propriate for determining plasmid content in this case, it is not a measure of the number of cells containing 
plasmid or of the intracellular plasmid content, but a measure of the proportion of dividing culturable cells 
containing plasmid.
Recombinant protein overexpression places a severe metabolic burden on host cells and its debilitating effects 
are well known30,31. It drains resources such as energy, precursor metabolites and protein synthesizing machin-
ery from host cell metabolism and leads to metabolic imbalances, reduced growth rates and cell disruption and 
death. In the present study, this was manifested by a reduced biomass accumulation (Fig. 1), loss of cell cultura-
bility (Fig. 3), loss of membrane integrity (Fig. 4), alteration in cell morphology (Fig. 5) and increased byproduct 
formation (Figs 1 and 6) as well as, eventually, cell disruption (Fig. 6). Interestingly, while a rapid loss of cell 
culturability was seen with all constructs following induction (Fig. 3), this loss was more rapid with the AmpR 
construct, and together with the higher rate of loss of membrane integrity (Fig. 4) indicates a reduced fitness of 
cells with this construct as compared to those with the SCS system. This apparent stimulating effect of the SCS 
system on host cells may initially appear somewhat counterintuitive, as the increased SELP production of these 
would be expected to impact a greater metabolic burden, and indeed the higher lactic acid production of these 
(Fig. 1) is reflective of an increased metabolic deregulation resultant of this higher SELP production. However, 
the SCS system prevents growth of plasmid-free cells, whereas with the AmpR construct these can compete with 
and outgrow the plasmid-bearing cells for nutrients, energy and other resources27,30,37,38. This competition could 
impose an additional stress on the host cells and, consequently, may induce the increased rate of loss of culturabil-
ity and membrane integrity observed, as well as, most importantly, the reduced SELP productivity with the AmpR 
system under the conditions used. Thus, hereby, it is suggested that with the controlled fed-batch conditions 
used here, the SCS system does not enable significantly increased plasmid content as compared to with AmpR, 
but it is an improved cell fitness, due to the absence of competition between plasmid-bearing and plasmid-free 
cells, that enables improved SELP productivity with this system. It can also be seen that plasmid content, in fact, 
increases following induction and that the principle limiting factor for improved productivity is the metabolic 
burden imposed on the host cells as a result of the recombinant protein overexpression. Indeed, this is already 
well described in the literature30,31,33 and a recent study took successful initial steps in addressing this for the high 
level production of a recombinant silk protein with a high glycine content by metabolically engineering the host 
for an increased glycyl-tRNA pool39,40. SELP is also characterised by a highly repetitive sequence and hence a sim-
ilar metabolic approach combined with our scalable antibiotic free technique described here may aid in further 
increasing yields and in better enhancing the economic feasibility of this novel biopolymer.
Conclusions
Protein based polymers are being explored as the next generation of biomaterials and a critical step in the stra-
tegic analysis of their viability is a demonstration of their cost effective production in a format suitable and safe 
for use in clinical practice. In this study, a scalable, reproducible, industrially relevant production process has 
been developed for the high level production of a novel SELP with total elimination of the use of antibiotics and 
antibiotic selection markers. It was shown that use of a post-segregational suicide system, SCS, for the fed-batch 
production of SELP-59-A in E. coli significantly enhanced productivity as compared to the use of antibiotic selec-
tion markers. Furthermore, an in-depth characterisation of the process provided insights into the operation of 
the stabilisation systems and production process and it is suggested that an improved viability of host cells plays a 
role in the observed increased productivity with SCS.
www.nature.com/scientificreports/
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Methods
SELP Polymer. SELP-59-A was used in this study, this consists of a nine times repeated copolymer unit 
composed of five repeats of the silk amino acid consensus sequence (GAGAGS) and nine repeats of an elastin 
mimetic sequence (VPAVG)21.
Vector Constructs. All expression vectors used are based on the pET expression vector system (Novagen) 
and all vector constructs prepared here were confirmed by restriction digestion and agarose gel analyses.
SELP-59-A/pET25bAmpR. The gene for SELP-59-A had already been inserted in a modified pET25b(+ )vector 
(Novagen) for expression in E. coli BL21(DE3)12, this vector contains the ampicillin resistance selective marker 
gene encoding β -lactamase.
SELP-59-A/pET29aKanR. For the kanamycin resistance marker (neomycin phosphotransferase II), the expres-
sion vector pET29a(+ ) (Novagen) was used. The SELP-59-A gene was excised from SELP-59-A/pET25bAmpR 
by digestion with NdeI and BlpI and ligated with T4 DNA ligase into similarly digested pET29a(+ ). Plasmid 
constructs were transformed to E. coli BL21(DE3) for expression.
SELP-59-A/pStaby1.2SCSAmpR. For the separate-component-stabilisation system (SCS), the expression vector 
pStaby1.2 (Delphi Genetics) was used. In addition to SCS, this vector also carries the ampicillin resistance marker, 
it is a variant of pET21a(+ ) in which the gene for the antitoxin ccdA has been inserted. The SELP-59-A gene was 
excised from SELP-59-A/pET25bAmpR by digestion with NdeI and BlpI and ligated with T4 DNA ligase into 
similarly digested pStaby1.2. Plasmid constructs were first transformed to the cloning host E. coli CYS21 (Delphi 
Genetics) before transformation to the expression host E. coli SE1 (Delphi Genetics), this is a variant of E. coli 
BL21(DE3) with a chromosomal copy of the gene for the ccdB toxin.
SELP-59-A/pStaby1.2SCS. The β -lactamase gene and promotor were removed from SELP-59-A/pSta-
by1.2SCSAmpR by digestion with SspI and Eam1105I, purified fragments were converted to blunt ended frag-
ments by treatment with Accuzyme mix (Bioline) for 30 mins at 72 °C and re-circularised with T4 DNA ligase. 
Plasmid constructs were transformed to E. coli SE1 (Delphi Genetics) for expression.
Fed-Batch Production. Fed-batch fermentations were performed as previously described22 in a BioFlo 110 
Modular Benchtop 3 L fermentor (New Brunswick Scientific, NBS). The whole process involved two precultures 
followed by a production process composed of three phases (batch, fed-batch and induction) in the minimal 
medium MMLBM as described by Collins et al.22. The conditions used were as previously detailed22, namely: 
37 ± 1 °C, pH 6.8 ± 0.1 (25% w/w NH4OH and 3 M H3PO4), minimum dissolved oxygen concentration = 25% 
(batch phase) and 35% (fed-batch phase) with control by cascading to agitation (200–1100 rpm) and O2 feeding 
(only during the fed-batch phase), gas (air, air + O2) flow rate = 5 L min−1 and antifoam Y-30 emulsion for foam-
ing control (Sigma). 200 μ g/mL ampicillin was used for all precultures and production cultures with the AmpR 
constructs and 100 μ g/mL kanamycin was used for the KanR construct while no antibiotic was included for the 
SELP-59-A/pStaby1.2SCS construct. All fed-batch studies were repeated at least three times.
For the comparative study of fed-batch productions with the four different vector constructs, a pre-induction 
growth rate of 0.5 h−1, post-induction growth rate of 0.1 h−1 and induction at a dry cell weight of 25 g L−1 with 
3 mM IPTG for 8 hours was used. Here, a higher IPTG concentration (3 mM IPTG) was used than that previously 
recommended (1 mM IPTG21) as this has been shown to have a greater negative effect on the proportion of plas-
mid containing culturable cells while not affecting the final product yield21.
Maximum achievable SELP-59-A productivity was determined for the construct identified as enabling high-
est plasmid stability by use of the previously optimised fed batch production process22 wherein a pre-induction 
growth rate of 0.4 h−1, post-induction growth rate of 0.1 h−1 and induction at a dry cell weight of 75 g L−1 with 
1 mM IPTG was used. The post induction period was optimised by examining productivities and process param-
eters after 4, 8 and 12 hours post induction incubation.
Process Monitoring. Process parameters such as glucose, ethanol, organic acids (citric, tartaric, malic, suc-
cinic, lactic, acetic and formic), phosphate, nitrogen and biomass concentrations were analysed and compared as 
previously described22.
SELP Production Quantification. SELP production levels for the various constructs were determined by weight 
measurements of purified product as previously described12,22. A previously developed non-chromatographic 
approach was used for purification12. This involved cell disruption by sonication, overnight acid treatment at pH 
3.5 to denature contaminants, centrifugation and SELP precipitation with 20% ammonium sulphate. Following 
centrifugation, resuspension and dialysis in distilled water, the purified SELP was then lyophilied and weighed.
Culturable cell count. Samples were taken at the time of induction and every hour thereafter, serially diluted in 
sterile phosphate buffered saline (PBS: 8 g L−1 NaCl, 0.2 g L−1 KCl, 1.44 g L−1 Na2HPO4, 0.24 g L−1 KH2PO4, pH 
7.4) and 25 μ L of the 10−3–10−7 dilutions spread plated in triplicate on LB plates (10 g L−1 bacto tryptone, 5 g L−1 
yeast extract, 5 g L−1 NaCl, 18 g L−1 agar, pH 7) and incubated overnight at 37 °C.
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Culturable Cell Plasmid Stability. 100 colony forming units of the culturable cell count study were repicked to 
LB + ampicillin (200 μ g mL ampicillin) plates and incubated overnight at 37 °C before enumeration.
Agarose Gel Electrophoresis for Plasmid Quantification. Plasmid content was evaluated at the time of induction 
and every two hours thereafter. The OD600nm of culture samples was measured and cell pellets washed twice in 
PBS before resuspension and dilution in TE buffer (50 mM Tris, 1 mM EDTA, pH 8) to an OD600nm of 2. This was 
followed by chemical lysis and chromosomal DNA removal with the lysis and precipitation reagents (buffers A1, 
A2 and A3) of the NucleoSpin Plasmid Kit (Macherey-Nagel) as described by the manufacturer. 400 μ L of plas-
mid extract was concentrated by precipitation with 50% isopropanol overnight at − 20 °C, resuspended in 100 μ L 
water and 20 μ L loaded on midori green stained 1% agarose gels for visualization and band intensity comparison.
qPCR for Relative Plasmid Quantification. Quantitative PCR (qPCR) was used to monitor the relative plasmid 
content during the fed-batch productions. The OD600nm of culture samples was measured and cell pellets washed 
twice in PBS before resuspension and dilution in TE buffer to an OD600nm of 1. Following treatment of 100 μ L 
sample with 50 μ g/mL RNase A, cells were disrupted by addition of 2% SDS and heating at 75 °C for 5 minutes. 
Supernatants were diluted 104-fold in water before qPCR analysis. qPCR reactions were performed in duplicate 
for each sample on a CFX96 Touch™ Real-Time PCR detection system (Bio-rad) with Sso7d fusion polymerase 
and EvaGreen® dye (SsoFast™ EVAGreen® Supermix, Bio-Rad). Data were analysed with the CFX Manager 
TMSoftware v3.1 (Bio-Rad). PCR conditions used were: denaturation at 95 °C for 3 minutes followed by 40 cycles 
of denaturation at 95 °C for 10 s and annealing/extension for 10 s at 63 °C (plasmid) or 60 °C (host chromosome). 
Amplification specificity and absence of reaction contaminants were confirmed by analysis of melting curves 
following heating of amplification products from 60 to 95 °C.
For qPCR analysis a variation of the protocol described by Lee et al. 200641 was used in which both plasmid 
and host chromosome content are monitored so as to eliminate sample preparation and processing variations. 
Primers were designed (GATCCGGCTGCTAACAAAGC; TTAGAGGCCCCAAGGGGTTA) to amplify an 89 bp 
fragment present on all four vector constructs studied. 0.25 μ M primers and an annealing/extension temperature 
of 63 °C with an amplification efficiency of 102.4% and R2 of 0.987 were used. For monitoring of host chromo-
some content, 0.25 μ M primers (ACAAAACGCATATCGACCAGC; GCGATCCTTAACTTTGGTACGC) and an 
annealing/extension temperature of 60 °C were employed to amplify an 86 bp fragment present on the E. coli chro-
mosomal d-1-deoxyxylulose 5-phosphate synthase (dxs) sequence with an amplification efficiency of 103.3% and 
R2 of 0.994. Relative quantification was performed by the Δ Δ CT (Δ Δ threshold cycle) method41,42 and results are 
expressed as a fold ratio of the normalized plasmid amount.
Flow Cytometry. Propidium iodide was used as a probe of membrane integrity with the flow cytometry analysis 
of samples collected at induction and every two hours thereafter. Culture samples were diluted 102-fold in PBS 
and stained with 1 μ g/mL propidium iodide (Sigma) for 10 minutes in the dark at room temperature. Analysis was 
performed with an EPICS® XL™ flow cytometer (Beckman Coulter) at a flow rate of 200–500 events per second. 
The cell population was gated in a histogram of Side Scatter (SS) versus Forward Scatter (fs) and monoparametric 
detection of propidium iodide fluorescence was performed using FL-3 (488/620 nm). Twenty thousand cells were 
analysed per sample.
Scanning Electron Microscopy. 10-fold dilutions of culture samples collected at the time of induction and at 2 hourly 
intervals until the end of fermentation were analysed by scanning electron microscopy (SEM). Samples were fixed to 
plastic disc supports by treatment with 2.5% glutaraldehyde in PBS for 1 hour and dehydrated by successive 30 min-
ute immersions in ethanol solutions of increasing concentration (55, 70, 80, 90, 95 and 100% v/v ethanol in water). 
Following drying at room temperature overnight, samples were coated with a thin gold layer using a Polaron model 
SC502 sputter coater and visualised on a NanoSEM-FEI Nova 200 scanning electron microscope (Leica Cambridge).
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